A U.S. judge rejected a bid by compounding pharmacies to keep making copies of Novo Nordisk’s popular drugs Ozempic and Wegovy while a legal challenge over drug shortages unfolds.
Read More Ozempic copies restricted after US judge denies injunctionTag: ozempic
15 Additional Drugs Chosen For Medicare Negotiation
The Centers for Medicare and Medicaid Services (CMS) has picked 15 more drugs for Medicare price negotiation.
Read More 15 Additional Drugs Chosen For Medicare NegotiationU.S. Obesity Rate Declines In 2023 Amid Rising Use Of Weight Loss Products
The U.S. obesity rate declined for the first time in a decade last year, coinciding with the rise of weight loss drugs such as Ozempic, a new study has found.
Read More U.S. Obesity Rate Declines In 2023 Amid Rising Use Of Weight Loss ProductsThe Significance Of The Trump-RFK Healthcare Revolution
By Rick Amato
November 14, 2024
(Views expressed by guest commentators may not reflect the views of OAN or its affiliates.)
Read More The Significance Of The Trump-RFK Healthcare RevolutionBernie Sanders Demands Novo Nordisk CEO Lower Weight Loss Drug Prices For Americans
During a Senate committee hearing on Tuesday, lawmakers questioned the manufacturer of popular weight loss drugs like Ozempic and Wegovy, citing what Senator Bernie Sanders called “outrageously high” drug prices.
Read More Bernie Sanders Demands Novo Nordisk CEO Lower Weight Loss Drug Prices For AmericansFDA Approves Wegovy To Reduce Heart Attack And Stroke Risk In Overweight Adults
The Food and Drug Administration (FDA) has approved the weight-loss drug Wegovy to reduce heart attack and stroke risk.
Read More FDA Approves Wegovy To Reduce Heart Attack And Stroke Risk In Overweight Adults